- Home
- ONB vs LEGN Comparison
ONB vs LEGN Comparison
Compare ONB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONB | LEGN |
|---|---|---|
| Founded | 1834 | 2014 |
| Country | United States | United States |
| Employees | 5243 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 5.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ONB | LEGN |
|---|---|---|
| Price | $21.45 | $16.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $26.83 | ★ $63.08 |
| AVG Volume (30 Days) | ★ 3.1M | 1.2M |
| Earning Date | 04-21-2026 | 03-10-2026 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.97 | $43.65 |
| Revenue Next Year | $5.16 | $32.75 |
| P/E Ratio | $13.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.83 | $16.24 |
| 52 Week High | $26.17 | $45.30 |
Technical Indicators
Market Signals| Indicator | ONB | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 34.29 | 37.37 |
| Support Level | $19.85 | $16.24 |
| Resistance Level | $21.65 | $20.39 |
| Average True Range (ATR) | 0.50 | 0.74 |
| MACD | 0.05 | -0.14 |
| Stochastic Oscillator | 29.97 | 0.56 |
Price Performance
Historical ComparisonAbout ONB Old National Bancorp
Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.